The results suggested that reduction of OSGIN1 expression represented poor overall survival (OS) (Figure 4A, p=0.0024), as well as poor disease-free survival (DFS) in DLBCL patients (Figure 4B, p=0.0091). The gene discussed is OSGIN1; the disease is diffuse large B-cell lymphoma.